XBiotech
XBIT
$7.87
Share price
-4.14%
Change (1 day)
140.67%
Change (1 year)
Categories
XBiotech (XBIT) - P/B ratio
P/B ratio as of April 2024 : 1.10
According to XBiotech's latest financial reports the company has a price-to-book ratio of 1.10.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
XBiotech - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.5563 | 25.18% |
| 2022-12-31 | 0.4444 | -64.62% |
| 2021-12-31 | 1.26 | -4.38% |
| 2020-12-31 | 1.31 | 28.07% |
| 2019-12-31 | 1.03 | -76.72% |
| 2018-12-31 | 4.41 | 89.82% |
| 2017-12-31 | 2.32 | -58.28% |
| 2016-12-31 | 5.56 | 63.36% |
| 2015-12-31 | 3.40 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 uniQure QURE | 1.05 | -4.66% | 🇳🇱 Netherlands |
 Calithera Biosciences
CALA | 0.0048 | -99.57% | 🇺🇸 USA |
 Enzo Biochem ENZ | 0.7636 | -30.62% | 🇺🇸 USA |